Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.
about
Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyAn introduction to proteoglycans and their localizationErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer.Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.
P2860
Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@ast
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@en
type
label
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@ast
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@en
prefLabel
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@ast
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@en
P2093
P2860
P356
P1476
Binding of trastuzumab to ErbB ...... ellular density of hyaluronan.
@en
P2093
Ferenc Jakab
Ferenc Salamon
István Besznyák
János Szöllősi
Markku Tammi
Peter Nagy
Päivi Auvinen
Raija Tammi
Tamás Mersich
Tímea Váradi
P2860
P304
P356
10.1369/0022155412448070
P577
2012-05-04T00:00:00Z